Vor Biopharma Inc. (VOR)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Vor Biopharma Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Vor Biopharma Inc. (VOR) has returned 36.39% so far this year and 24.32% over the past 12 months.

Based on dividend-adjusted daily data since Feb 5, 2021, VOR's average daily return is -0.01%, while the average monthly return is +6.01%. At this rate, your investment would double in approximately 1.0 years.

Historically, 42% of months were positive and 58% were negative. The best month was Jun 2025 with a return of +710.4%, while the worst month was May 2025 at -70.6%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 6 months.

On a daily basis, VOR closed higher 43% of trading days. The best single day was Jun 25, 2025 with a return of +74.3%, while the worst single day was May 8, 2025 at -70.1%.

Vor Biopharma Inc. has an annualized alpha of -16.17%, beta of 1.26, and R² of 0.03 versus S&P 500 Index. Calculated based on daily prices since February 08, 2021.

• This stock participated in 32.46% of S&P 500 Index downside but only -122.33% of its upside — more exposed to losses than it benefited from rallies.
• R² of 0.03 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

VOR ranks 57 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.

The table below present risk-adjusted performance metrics for Vor Biopharma Inc. (VOR) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Vor Biopharma Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Vor Biopharma Inc. was 99.72%, occurring on May 9, 2025. The portfolio has not yet recovered.

The current Vor Biopharma Inc. drawdown is 98.35%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Vor Biopharma Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Vor Biopharma Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.